Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Performer
2628.4000 24.80 (0.95%)
NSE May 19, 2025 15:31 PM
Volume: 86,375
 

logo
Ajanta Pharma Ltd.
10 Mar 2023
2628.40
0.95%
AJANTA PHARMA LTD. - 532331 - Board Meeting Outcome for Approving Buyback Of Equity Shares
BSE India
The Board of Directors of the Company, at its meeting held today, i.e., March 10, 2023, has inter-alia considered and approved Buyback of 22,10,500 fully paid-up Equity Shares of face value of ? 2/- each by the Company (representing 2.59% of the total number of Equity Shares of the Company as of March 31, 2022 (not adjusted for bonus issue undertaken by Company as on June 24, 2022 ) at a price of ? 1,425/- (Indian Rupees One Thousand Four Hundred Twenty Five only) per Equity Share payable in cash for a total consideration not exceeding ? 315 crores (Indian Rupees Three Hundred and Fifteen crores only) (excluding transaction costs such as fees, brokerage, taxes, duties, etc.), which represents 9.93% and 9.64% of the aggregate of the Company's paid-up capital and free reserves as per the standalone and consolidated audited financials of the Company for the year ended as on March 31, 2022 respectively.
More from Ajanta Pharma Ltd.
All earning calls
Investor presentations from Ajanta Pharma Ltd.
All investor presentations